U.S. federal trademark · Serial No. 87982539 · Reg. No. 5997775
Computer software for processing cancer/normal protein sets, identifying high-quality specific neo-antigens, and designing personalized cancer vaccines
Medical testing and analysis of cancerous and normal protein sets for identifying high-quality patient specific neo-antigens for the purpose of diagnosis and treatment
Research, development, engineering and testing services in the field of personalized cancer vaccines; providing temporary use of non-downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.